Rare biochemical & genetic conditions: clues for broader mechanistic insights. [PDF]
Mentis AA, Dalamaga M.
europepmc +1 more source
A new glucocerebrosidase chaperone reduces α-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with gaucher disease and parkinsonism [PDF]
et al, +3 more
core +1 more source
Niemann-Pick disease type C or Gaucher's disease type 3? A clinical conundrum. [PDF]
Pandi S +3 more
europepmc +1 more source
Advances in Cell and Gene Therapy for Rare Disease Treatment. [PDF]
Baek HJ, Nam Y, Rim YA, Ju JH.
europepmc +1 more source
A novel allosteric GCase modulator prevents Tau accumulation in GBA1<sup>WT</sup> and GBA1<sup>L444P/L444P</sup> cellular models. [PDF]
Ciccaldo M +13 more
europepmc +1 more source
Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients [PDF]
core +1 more source
A guide to selecting high-performing antibodies for GCase (UniProt ID: P04062) for use in western blot, immunoprecipitation, and immunofluorescence. [PDF]
Worrall D +8 more
europepmc +1 more source
Non-neuronopathic Gaucher disease (Type I) in an elderly female: a case report. [PDF]
Bohara S +7 more
europepmc +1 more source
Aseptic osteonecrosis of the jaw in a patient with HIV on tenofovir. [PDF]
Bhattarai S +4 more
europepmc +1 more source

